Cameco Corp (CCJ) concluded trading on Thursday at a closing price of $52.91, with 3.66 million shares of worth about $193.83 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 2.60% during that period and on December 19, 2024 the price saw a gain of about 1.89%. Currently the company’s common shares owned by public are about 435.18M shares, out of which, 433.32M shares are available for trading.
Stock saw a price change of -5.52% in past 5 days and over the past one month there was a price change of -7.92%. Year-to-date (YTD), CCJ shares are showing a performance of 22.76% which increased to 20.88% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $35.43 but also hit the highest price of $62.55 during that period. The average intraday trading volume for Cameco Corp shares is 4.63 million. The stock is currently trading -7.95% below its 20-day simple moving average (SMA20), while that difference is down -4.40% for SMA50 and it goes to 8.26% higher than SMA200.
Cameco Corp (NYSE: CCJ) currently have 435.18M outstanding shares and institutions hold larger chunk of about 76.52% of that.
The stock has a current market capitalization of $23.03B and its 3Y-monthly beta is at 0.95. PE ratio of stock for trailing 12 months is 269.54, while it has posted earnings per share of $0.20 in the same period. Its PEG reads 4.15 and has Quick Ratio of 1.26 while making debt-to-equity ratio of 0.21. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CCJ, volatility over the week remained 3.57% while standing at 3.87% over the month.
Stock’s fiscal year EPS is expected to drop by -24.82% while it is estimated to increase by 173.71% in next year. EPS is likely to grow at an annualized rate of 65.00% for next 5-years, compared to annual growth of 13.73% made by the stock over the past 5-years.
Coverage by Goldman stated Cameco Corp (CCJ) stock as a Buy in their note to investors on April 01, 2024, suggesting a price target of $55 for the stock. Stock get an Outperform rating from BMO Capital Markets on November 08, 2023.
